What We’re Reading: Global COVID-19 Deaths; J&J Vaccine Limited; Uterine Cancer Deaths on the Rise
New global data put the COVID-19 death toll at just under 15 million; the FDA issues a warning limiting use of Johnson & Johnson vaccine; US sees increase in aggressive uterine cancer cases.
Dr Kami J. Maddocks Highlights Progress of Last 5 Years in DLBCL
Kami J. Maddocks, MD, professor of clinical internal medicine in the Division of Hematology at The Ohio State University Wexner Medical Center, spoke with The American Journal of Managed Care® (AJMC®) about treatment approaches for diffuse large B-cell lymphoma (DLBCL).
What We’re Reading: Mavacamten Approved for HCM; Oklahoma Abortion Bans; Baby Formula Whistleblower
A new drug has been approved for obstructive hypertrophic cardiomyopathy (HCM); Oklahoma enacts a strict abortion ban; whistleblower claims alarms had been raised about Abbott baby formula contamination.
Avalere's Ryan Urgo on the Biden Administration's Options to Tackle Drug Pricing
Avalere is presenting at Asembia’s 2022 Specialty Pharmacy Summit, and Ryan Urgo, MPAP, managing director, health policy, discusses possible drug pricing policy options on the table for the Biden administration to consider in a midterm election year.
Dr Martin Dietrich Describes Need to Move Quickly With “Aggressive, Unpredictable” Melanoma
Martin Dietrich, MD, PhD, of Florida Cancer Specialists spoke with The American Journal of Managed Care® (AJMC®) on risk factors in melanoma, as well as the need for genomic testing and rapid action for a cancer that can progress very quickly.